The Pancreatic Cancer Action Network Announces Leadership Updates to its Board of Directors and Scientific Medical Advisory Board for FY2027
Jul 1, 2026 - By Charaighn Sesock LOS ANGELES, CALIF. – (July 1, 2026) – The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to fighting pancreatic cancer…
Read the full articleYou might also wanna read
New AI Tool Boosts Pancreatic Cancer Detection – Asian Scientist Magazine
In a new study published in Nature Communications, a multidisciplinary team from National Taiwan University Hospital and Academia Sinica dev
PNAS republica con modificaciones el polémico estudio de Barbacid sobre cáncer de páncreas tras retractación por conflictos de intereses no declarados
El nuevo trabajo está disponible en ‘PNAS’ con múltiples modificaciones con respecto al original, retractado por no informar de los interese
social.elpais.com·1mo agoAnirban Maitra: Full House at the Inaugural Cancer Research UK Pancreatic Cancer Meeting 2026
Anirban Maitra, Laura and Isaac Perlmutter Professor of Pathology and Director of the Perlmutter Cancer Center, shared a post by Giulia Biff
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
Conditions : Pancreatic Cancer Interventions : Drug: SBRT + Ipilimumab N01 + Sintilimab + AG Chemotherapy Sponsors : Shandong Cancer Hospita
Top 10 Pancreatic Cancer Updates – June 2026
June 2026 brought a wide range of important updates across pancreatic cancer and related GI oncology, from RAS-targeted therapy and chemothe
Patient-Derived Organoid-on-a-Chip Model for Personalized Prediction of Chemotherapy Efficacy in Pancreatic Cancer
Conditions : Pancreatic Ductal Adenocarcinoma (PDAC) Sponsors : Beijing Daxiang Biotech Co., Ltd; Ruijin Hospital; Beijing Friendship Hospit
Comments
Sign in to join the conversation.
No comments yet. Be the first.